Black Rock Inc. Nemaura Medical Inc. Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.32 - $1.14 $352 - $1,255	-1,101 Reduced 23.71%	3,542 $1,000
Q2 2023 Aug 11, 2023	SELL	$0.49 - $0.93 $13,784 - $26,161	-28,131 Reduced 85.83%	4,643 $4,000
Q1 2023 May 12, 2023	BUY	$0.71 - $2.86 $639 - $2,574	900 Added 2.82%	32,774 $29,000
Q4 2022 Feb 13, 2023	BUY	$1.72 - $3.13 $1,032 - $1,878	600 Added 1.92%	31,874 $54,000
Q3 2022 Nov 14, 2022	SELL	$1.52 - $2.57 $1,140 - $1,927	-750 Reduced 2.34%	31,274 $65,000
Q2 2022 Aug 12, 2022	SELL	$2.53 - $4.42 $1,138 - $1,989	-450 Reduced 1.39%	32,024 $83,000
Q1 2022 May 12, 2022	SELL	$3.78 - $4.66 $5,103 - $6,291	-1,350 Reduced 3.99%	32,474 $142,000
Q4 2021 Feb 10, 2022	SELL	$4.12 - $6.35 $4,008 - $6,178	-973 Reduced 2.8%	33,824 $155,000
Q3 2021 Nov 09, 2021	SELL	$5.76 - $9.95 $3,755 - $6,487	-652 Reduced 1.84%	34,797 $210,000
Q2 2021 Aug 11, 2021	BUY	$4.7 - $16.7 $166,610 - $591,998	35,449 New	35,449 $366,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.